Baird raised the firm’s price target on Cardinal Health (CAH) to $232 from $208 and keeps an Outperform rating on the shares. The firm updated its model following Q1 results.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CAH:
- Cardinal Health price target raised to $190 from $165 at Citi
- Cardinal Health Reports Strong Revenue Growth in Latest Quarter
- Cardinal Health price target raised to $216 from $180 at BofA
- Early notable gainers among liquid option names on October 30th
- Morning Movers: Alphabet, Eli Lilly rise following quarterly results